Chakrabarti Bimal K, Ling Xu, Yang Zhi-Yong, Montefiori David C, Panet Amos, Kong Wing-Pui, Welcher Brent, Louder Mark K, Mascola John R, Nabel Gary J
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg. 40, Room 4502, MSC 3005, 40 Convent Drive, Bethesda, MD 20892-3005, USA.
Vaccine. 2005 May 16;23(26):3434-45. doi: 10.1016/j.vaccine.2005.01.099.
Although the V3 loop of the human immunodeficiency virus type 1 (HIV-1) envelope (Env) effectively elicits potent neutralizing antibody responses, the specificity of the antibody response is often restricted to T cell line adapted (TCLA) strains and a small subset of primary isolates, limiting its utility for an AIDS vaccine. In this study, we have compared Env immunogens with substituted V3 regions to combinations of strains from different clades and evaluated their ability to expand the breadth of the neutralizing antibody response. When the V3 region from HIV BaL was substituted for HIV HXB2, an effective neutralizing antibody response against several clade B primary isolates was elicited, but it remained restricted to neutralization of most clade B isolates. In an attempt to expand this response further, a linear epitope recognized by the broadly neutralizing 2F5 antibody was inserted into V3. A V3 2F5 epitope was identified that bound to 2F5 and elicited a potent 2F5 antibody response as an immunogen, but the antisera neutralized only a lab-adapted strain and not primary isolates. In contrast, combinations of Envs from clades A, B, and C, elicited neutralizing antibodies to a more diverse group of primary HIV-1 isolates. These studies suggest that combinations of Env immunogens, despite the limited reactivity of the V3 from each component, can be used to expand the breadth of the neutralizing antibody response.
尽管人类免疫缺陷病毒1型(HIV-1)包膜糖蛋白(Env)的V3环能有效引发强效中和抗体反应,但抗体反应的特异性通常局限于T细胞系适应株(TCLA)和一小部分原代分离株,限制了其在艾滋病疫苗中的应用。在本研究中,我们将具有替代V3区域的Env免疫原与来自不同分支的毒株组合进行了比较,并评估了它们扩展中和抗体反应广度的能力。当用HIV BaL的V3区域替代HIV HXB2的V3区域时,引发了针对几种B分支原代分离株的有效中和抗体反应,但仍局限于对大多数B分支分离株的中和。为了进一步扩大这种反应,将广谱中和性2F5抗体识别的线性表位插入V3。鉴定出一个与2F5结合并作为免疫原引发强效2F5抗体反应的V3 2F5表位,但抗血清仅中和一种实验室适应株,而不能中和原代分离株。相比之下,A、B和C分支的Env组合引发了针对更多种类原代HIV-1分离株的中和抗体。这些研究表明,尽管每个组分的V3反应性有限,但Env免疫原组合可用于扩大中和抗体反应的广度。